Distal weakness with respiratory insufficiency caused by the m.8344A>G “MERRF” mutation  by Blakely, Emma L. et al.
Available online at www.sciencedirect.comwww.elsevier.com/locate/nmd
ScienceDirect
Neuromuscular Disorders 24 (2014) 533–536Case report
Distal weakness with respiratory insuﬃciency caused by the
m.8344A > G “MERRF” mutation
Emma L. Blakely a, Charlotte L. Alston a, Bryan Lecky b, Biswajit Chakrabarti c,
Gavin Falkous a, Douglass M. Turnbull a, Robert W. Taylor a, Grainne S. Gorman a,⇑
aWellcome Trust Centre for Mitochondrial Research, Institute for Ageing and Health, The Medical School, Newcastle University,
Newcastle upon Tyne NE2 2HH, UK
bThe Walton Centre NHS Foundation Trust, Liverpool L9 7LJ, UK
cAintree Chest Centre, University Hospital Aintree, Liverpool L9 7AL, UK
Received 5 January 2014; received in revised form 7 March 2014; accepted 20 March 2014Abstract
The m.8344A > G mutation in the mt-tRNALys gene, ﬁrst described in myoclonic epilepsy and ragged red ﬁbers (MERRF), accounts
for approximately 80% of mutations in individuals with MERRF syndrome. Although originally described in families with a classical
syndrome of myoclonus, ataxia, epilepsy and ragged red ﬁbers in muscle biopsy, the m.8344A > G mutation is increasingly
recognised to exhibit marked phenotypic heterogeneity. This paper describes the clinical, morphological and laboratory features of
an unusual phenotype in a patient harboring the m.8344A > G ‘MERRF’ mutation. We present the case of a middle-aged woman
with distal weakness since childhood who also had ptosis and facial weakness and who developed mid-life respiratory insuﬃciency
necessitating non-invasive nocturnal ventilator support. Neurophysiological and acetylcholine receptor antibody analyses excluded
myasthenia gravis whilst molecular genetic testing excluded myotonic dystrophy, prompting a diagnostic needle muscle biopsy.
Mitochondrial histochemical abnormalities including subsarcolemmal mitochondrial accumulation (ragged-red ﬁbers) and in excess of
90% COX-deﬁcient ﬁbers, was seen leading to sequencing of the mitochondrial genome in muscle. This identiﬁed the m.8344A > G
mutation commonly associated with the MERRF phenotype. This case extends the evolving phenotypic spectrum of the
m.8344A > G mutation and emphasizes that it may cause indolent distal weakness with respiratory insuﬃciency, with marked
histochemical defects in muscle. Our ﬁndings support consideration of screening of this gene in cases of indolent myopathy
resembling distal limb-girdle muscular dystrophy in which screening of the common genes prove negative.
 2014 The Authors. Published by Elsevier B.V. This is an open access article under the CC BY license (http://creativecommons.org/
licenses/by/3.0/).
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Myoclonic Epilepsy with Ragged-Red Fibers (MERRF)
is a rare disorder [1], characterized by myoclonic epilepsyhttp://dx.doi.org/10.1016/j.nmd.2014.03.011
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dysfunction [2], frequently caused by the m.8344A > G
mt-tRNALys (MTTK) gene mutation [3]. Although the
major features of MERRF include myoclonus, generalized
epilepsy, ataxia and ragged red ﬁbers in the muscle
biopsy [2,3], it is increasingly recognized that phenotypic
heterogeneity is common [4]. We describe a 42-year-old
woman who presented with indolent, predominantly distal
myopathy and respiratory insuﬃciency not previouslys.org/licenses/by/3.0/).
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signiﬁcant evidence of mitochondrial histochemical
abnormalities which led to a diagnosis. This study was
approved and performed under the ethical guidelines issued
by our institution and complied with the declaration of
Helsinki.2. Patient and methods
2.1. Case report
A 42-year-old woman, born with congenital talipes
equinovarus presented with slowly progressive hand
weakness, reduced exercise tolerance since childhood and
increasing dyspnea on exertion, migraine and treated
hypothyroidism. Her mother had a cardiac pacemaker
and her sister had epilepsy, but no evidence of myopathy.
Her brother had ptosis, obstructive sleep apnea requiring
non-invasive nocturnal ventilatory support and died of a
pulmonary embolism aged 40 years. Examination showed
a stature of 1.58 m, ptosis, slowed pursuit eye movements
but no signiﬁcant restriction, striking lower facial
weakness and distal limb weakness (MRC grade 4) with
relative sparing of proximal musculature, with retained
tendon reﬂexes and normal sensation (Fig. 1A).
Myotonia was not found. Creatine kinase level was
normal and plasma lactic acid was raised (3.0 mmol/L
normal <2.1). Nerve conduction studies and EMG,
including SFEMG were normal. MRI brain imaging was
not performed. Acetylcholine receptor antibody assay
was negative. Cardiologic workup was normal. Forced
vital capacity in the erect position was 2.0 L, and
reduced to 1.5 L in the supine position, suggestive ofFig. 1. (A) Clinical features include hair thinning, bilateral ptosis, and marke
and mild neck ﬂexor and extension weakness. (B) Illustrates a severe mitochon
accumulation (ragged-red ﬁbers) on the SDH reaction and in excess of 90%
histochemistry. (E) Sequencing of the mitochondrial genome identiﬁed the well
present at very high levels of heteroplasmy in the patient’s skeletal muscle (
pyrosequencing. (F) Analysis of samples from the patient’s clinically-unaﬀecte
sister (3% mutation load in blood; 4% mutation load in urine) conﬁrmed lower
the mutation could not be detected in blood from her clinically-unaﬀected 14diaphragmatic weakness. Arterial blood gases on room
air showed an elevated paCO2 of 6.13 kPa (pH 7.39 and
PO2 10.83) indicating hypercapnia. Overnight oximetry
showed that she spent 38 min below 90% oxygen
saturation and 26 min below 88% oxygen saturation,
indicative of hypoventilation. Non-invasive nocturnal
ventilatory support was commenced. Molecular genetic
testing excluded myotonic dystrophy prompting a
diagnostic needle muscle biopsy.
2.2. Histopathology and molecular genetic studies
Standard histopathological analysis of muscle was
undertaken. Total genomic DNA was extracted from
blood, urinary epithelium and skeletal muscle using
standard procedures. Mitochondrial DNA rearrangements
were investigated in muscle by long-range PCR whilst
direct sequencing of the entire mitochondrial genome was
undertaken as previously described [5]. Ampliﬁed PCR
products were sequenced using BigDye Terminator v3.1
chemistries (Applied Biosystems) and compared to the
revised Cambridge reference sequence (GenBank Accession
number NC_012920.1). Quantiﬁcation of m.8344A > G
mutation load by pyrosequencing [6], was performed
using mutation-speciﬁc primers (details available on
request).
3. Results
Muscle biopsy analysis showed remarkable
mitochondrial histochemical abnormalities characterized
by subsarcolemmal mitochondrial accumulation
(ragged-blue ﬁbers) on the SDH reaction (Fig. 1B) and ind facial diplegia with prominent temporalis muscle wasting, jaw weakness
drial histochemical defect, characterized by subsarcolemmal mitochondrial
COX-deﬁcient ﬁbers following COX (C) and sequential COX-SDH (D)
-characterised m.8344A > GMTTK gene mutation which was shown to be
94% mutation load) but lower levels in blood and urine by quantitative
d mother (16% mutation load in blood; 18% mutation load in urine) and
levels of the m.8344A > G heteroplasmy and maternal transmission, whilst
year-old nephew.
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prompting genetic studies to investigate a likely
mitochondrial etiology. Long-range PCR across the
major mtDNA arc revealed no evidence of mtDNA
rearrangements, and a screen for the m.3243A > G
mutation was negative. Sequencing of the mitochondrial
genome in muscle identiﬁed the well-characterised
m.8344A > G mutation commonly associated with the
MERRF phenotype (Fig. 1E). Quantitative
pyrosequencing conﬁrmed the m.8344A > G mutation to
be present at very high levels of heteroplasmy in the
patient’s skeletal muscle (94% mutation load) but lower
levels in blood (38%) and urine (37%) (Fig. 1F). Analysis
of samples from the patient’s clinically unaﬀected mother
(16% mutation load in blood; 18% mutation load in
urine) and sister (3% mutation load in blood; 4%
mutation load in urine) conﬁrmed lower levels of
m.8344A > G heteroplasmy and maternal transmission,
whilst the mutation could not be detected in blood from
her clinically unaﬀected 14 year-old nephew.
Unfortunately, tissue samples were unavailable from her
deceased brother or maternal grandmother for
mutational analysis.4. Discussion
We report a 42-year-old woman with exceptional clinical
and histological features of the m.8344A > G mutation;
very high levels of the mutation were detected in skeletal
muscle, associated with ptosis, marked facial and distal
muscle weakness, respiratory insuﬃciency and severe
COX deﬁciency. To date, over 300 patients with
MERRF syndrome due to the m.8344A > G mutation
have been described [4], and more than 40 m.8344A > G
patients have been reviewed at our centre; none appear to
share this unusual clinical and histochemical phenotype.
Moreover, facial weakness is a relatively uncommon
muscle manifestation of mitochondrial disorders. The
marked mitochondrial histochemical abnormalities were
suggestive of a pathogenic mtDNA mutation, exhibiting
high mutation threshold. However, due to the severity of
the histochemical defect with in excess of 90%
COX-deﬁcient ﬁbers in the muscle biopsy, and with a
phenotype strongly suggestive of a limb girdle muscular
dystrophy initial genetic testing was directed to whole
mtDNA genome sequencing in preference to targeted
m.8344A > G mutation analysis. Biopsy ﬁndings,
combined with the conspicuous discrepancy in the
segregation of m.8344 > G mutation load between tissues,
we suggest, accounts for the myopathic phenotype
although potential cis-acting modiﬁers were not evaluated
[7].
In conclusion, this case emphasizes that the
m.8344A > G mutation can cause indolent distal
weakness with respiratory insuﬃciency, with marked
histochemical defects in muscle and extends the evolvingphenotypic spectrum attributable to the m.8344A > G
“MERRF” mutation.
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